Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 24209569)

1.

Re: Loss of β1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype.

Atala A.

J Urol. 2013 Dec;190(6):2305. doi: 10.1016/j.juro.2013.08.055. Epub 2013 Aug 30. No abstract available.

PMID:
24209569
2.

Re: Loss of β1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype.

Wein AJ.

J Urol. 2014 Mar;191(3):869-70. doi: 10.1016/j.juro.2013.11.093. Epub 2013 Dec 3. No abstract available.

PMID:
24522081
3.

Loss of β1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype.

Kanasaki K, Yu W, von Bodungen M, Larigakis JD, Kanasaki M, Ayala de la Pena F, Kalluri R, Hill WG.

FASEB J. 2013 May;27(5):1950-61. doi: 10.1096/fj.12-223404. Epub 2013 Feb 8.

4.

Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder.

Araki I, Du S, Kobayashi H, Sawada N, Mochizuki T, Zakoji H, Takeda M.

Int J Urol. 2008 Aug;15(8):681-7. doi: 10.1111/j.1442-2042.2008.02052.x. Epub 2008 May 2. Review.

PMID:
18462357
5.

Mechanical and physicochemical responses for hyaline cartilage: role of protein β1 integrin in mechanotransduction.

Cueru L, Bougault C, Aszodi A, Berthier Y, Mallein-Gerin F, Sfarghiu AM.

Comput Methods Biomech Biomed Engin. 2013;16 Suppl 1:330-1. doi: 10.1080/10255842.2013.815947. No abstract available.

PMID:
23923962
6.

Antimuscarinics and overactive bladder: other mechanism of action.

Yamaguchi O.

Neurourol Urodyn. 2010;29(1):112-5. doi: 10.1002/nau.20796. Review.

PMID:
19693952
7.

The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.

Andersson KE, Gratzke C, Hedlund P.

BJU Int. 2010 Oct;106(8):1114-27. doi: 10.1111/j.1464-410X.2010.09650.x. Review.

PMID:
21156013
8.

In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic.

Kumar V, Chapple CR, Rosario D, Tophill PR, Chess-Williams R.

Eur Urol. 2010 Jun;57(6):1087-92. doi: 10.1016/j.eururo.2009.11.042. Epub 2009 Dec 3.

PMID:
20022422
9.

A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature.

Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE.

Eur Urol. 2009 Nov;56(5):810-9. doi: 10.1016/j.eururo.2009.07.044. Epub 2009 Aug 4. Review.

PMID:
19683859
10.

The afferent system and its role in lower urinary tract dysfunction.

Daly DM, Collins VM, Chapple CR, Grundy D.

Curr Opin Urol. 2011 Jul;21(4):268-74. doi: 10.1097/MOU.0b013e3283476ea2. Review.

PMID:
21537194
11.

Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat.

Tong YC, Cheng JT.

J Urol. 2007 Oct;178(4 Pt 1):1537-42. Epub 2007 Aug 16.

PMID:
17707055
12.

The bladder epithelium and overactive bladder: what we know.

Moore CK, Goldman HB.

Curr Urol Rep. 2006 Nov;7(6):447-9. Review.

PMID:
17052439
13.

Researching bladder afferents-determining the effects of β(3) -adrenergic receptor agonists and botulinum toxin type-A.

Kanai A, Wyndaele JJ, Andersson KE, Fry C, Ikeda Y, Zabbarova I, De Wachter S.

Neurourol Urodyn. 2011 Jun;30(5):684-91. doi: 10.1002/nau.21102. Review.

PMID:
21661014
14.
15.
16.

Insight into new potential targets for the treatment of overactive bladder and detrusor overactivity.

Cerruto MA, Asimakopoulos AD, Artibani W, Del Popolo G, La Martina M, Carone R, Finazzi-Agrò E.

Urol Int. 2012;89(1):1-8. doi: 10.1159/000339251. Epub 2012 Jun 27. Review.

17.

Lower urinary tract dysfunction: From basic science to clinical management. Foreword.

de Groat WC.

Int J Urol. 2013 Jan;20(1):3. No abstract available.

PMID:
23819142
18.
19.
20.

Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.

Andersson KE.

Int J Clin Pract Suppl. 2006 Dec;(151):8-16. Review.

PMID:
17169005
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk